$BWXT

Bwx technologies targets $5.5B-$6B revenue and $1.1B-$1.2B adjusted EBITDA by 2030 while raising 2026 free cash flow floor to $350M (NYSE:BWXT)

BWX Technologies (BWXT) aims for $5.5B-$6B revenue and $1.1B-$1.2B adjusted EBITDA by 2030, raising its 2026 free cash flow target to $350M. The company provided these updated financial projections in a recent announcement.

Original reporting
Published Nov 3, 2026, 2:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bwx technologies targets $5.5B-$6B revenue and $1.1B-$1.2B adjusted EBITDA by 2030 while raising 2026 free cash flow floor to $350M (NYSE:BWXT) — source image
Decision brief

The 30-second read

$BWXTBullishHigh
01

Why it matters

The new guidance signals a significant revenue and earnings upside, likely prompting re‑rating by analysts.

02

Market read

Guidance upgrade is a primary corporate event that can move BWXT's stock and affect sector sentiment.

03

What to watch

Potential execution risk on long‑term projects and macro‑economic headwinds.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

BWXT is a US‑listed nuclear services company that provides components for power generation and defense.

Company-level read

Ticker impact

$BWXTBullishHigh confidence
Context

BWXT disclosed new 2026-2030 revenue and EBITDA guidance, raising targets to $5.5B-$6B revenue and $1.1B-$1.2B adjusted EBITDA.

Expected impact

potential upside as market prices in higher growth outlook

Evidence & confidence

Guidance lift is material and first reported, indicating improved fundamentals.

Market effects

May lift peers in the nuclear services and defense sector.

Positive for US industrial equities.

Limited to investors tracking BWXT and related defense contractors.

Counterpoint

If guidance proves overly optimistic, a correction could follow.

Key entities

  • Bwx Technologies, Inc.

    Issuer of the guidance.

Related articles

$BWXTMedAI 8/10

BWX Technologies Q3 Earnings Call Highlights

BWX Technologies reported Q3 highlights, including a $189M fuel contract and revenue growth in special materials. The company is advancing nuclear projects, such as a high-enriched uranium facility and a large-scale HPDU plant. BWXT also secured awards for its advanced nuclear reactors and raised its 2026 free-cash-flow outlook to $350M-$360M, maintaining adjusted EBITDA and EPS guidance.

$BWXTMed

BWX (NYSE:BWXT) misses Q3 2026 sales expectations

BWX reported Q3 2026 revenue of $953M, missing estimates by 2.1% but beating EPS expectations. Adjusted EBITDA and free cash flow margins improved. Management maintained full-year EPS guidance at $4.74 and raised EBITDA guidance. Backlog grew 15.6% year-on-year to $8.56B.

$BWXTMedAI 8/10

BWX Technologies beats earnings for a sixth straight quarter

BWX Technologies reported Q3 2026 adjusted EPS of $1.26, beating estimates for the sixth consecutive quarter. Revenue of $952.97 million missed expectations, but earnings growth was supported by lower interest and tax expenses. The company's backlog grew to $8.56 billion, and it reaffirmed 2026 revenue guidance of $3.8 billion while tightening its EPS range. Commercial Operations revenue increased 25%, while Government Operations grew 4%.